Alembic Reveals Pricing Challenges For US Sartans Amid Competition

As Indian Firm Reports FY21 Results

 
• By William Masters

Indian firm Alembic Pharmaceuticals discussed the challenges ahead for its US generics business while revealing a dramatic uptick in non-US overseas markets during its FY2021 financial earnings call.

business documents accounting with calculator and magnifying glass. concept for financial
"A lot of players are in the market," Alembic noted • Source: Shutterstock

More from Generics

More from Products